Tyra Biosciences, Inc. (TYRA)
33.02
-0.38
(-1.14%)
USD |
NASDAQ |
May 21, 16:00
33.00
-0.02
(-0.06%)
After-Hours: 19:59
Tyra Biosciences Total Liabilities (Quarterly) : 24.46M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 93.14M |
| Relay Therapeutics, Inc. | 57.43M |
| Tango Therapeutics, Inc. | 44.29M |
| Entrada Therapeutics, Inc. | 64.66M |
| BioMarin Pharmaceutical, Inc. | 2.379B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 412.04M |
| Shareholders Equity (Quarterly) | 387.58M |
| Debt to Equity Ratio | 0.0147 |
| Current Ratio | 20.49 |
| Net Debt Paydown Yield | 0.00% |